2011 Schedule
Sunday, July 17

7:30 a.m.-5 p.m. Registration

8-10 a.m. Awards ceremony/plenary session

PL-01 Plenary Session 1

PL-01-01 Genetics Studies of Alzheimer's Disease
Sudha Seshadri, Boston University, Boston, Mass., United States

PL-01-02 What Factors Might Prevent Dementia?
Eric B Larson, University of Washington, Seattle, Wash., United States

PL-01-03 Abeta Oligomer in Alzheimer's Disease
Hiroshi Mori, Department of Neuroscience, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka, Japan

10-10:30 a.m. Break

10 a.m.-5 p.m. Exhibit Hall open

10:30 a.m.-12:30 p.m. Invited Symposia and Featured Research Sessions

S1-01 Genome-wide Association Studies of Alzheimer's Disease

Chairs: Gerard D. Schellenberg, University of Pennsylvania School of Medicine, Philadelphia, Pa., United States
Philippe Amouyel, Institut Pasteur de Lille, Lille, France

S1-01-01 Results from Genome-wide Association Studies: GERAD Consortium
Amy Gerrish, MRC Centre for Neuropsychiatric Genetics and Genomics, Heath Park United Kingdom

S1-01-02 Genome-wide Association Studies Using Prospective Cohorts: the CHARGE Consortium
Anita DeStefano, Boston University, Boston, Mass., United States

S1-01-03 Genome-wide Association Studies: the EADI Consortium
Jean-Charles Lambert, Institut Pasteur de Lille, Lille, France

S1-01-04 Alzheimer's Disease Genetics Consortium: New Alzheimer's Disease Genes and Gene Interactions
Gary Beecham, University of Miami, Miami, Fla., United States

S1-01-05 Genome-wide Association Studies of CSF Biomarkers
John S.K. Kauwe, Ph.D., Brigham Young University, Provo, Utah, USA

S1-01-06 CNV and Pathway Analysis of Alzheimer's Disease GWAS Results
Li-San Wang, University of Pennsylvania School of Medicine, Philadelphia, Pa., United States

S1-02 Transgenic Models to Address Toxicity

Chairs: Cynthia Lemere, Brigham & Women's Hospital, Boston, Mass., United States
Jürgen Götz, Brain and Mind Research Institute, University of Sydney, Sydney, Australia

S1-02-01 Prion-like Properties of Tau
Michel Goedert, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom

S1-02-02 Excitotoxicity in Alzheimer's Disease or Network Dysfunction in Alzheimer's Disease
Lennart Mucke, Gladstone , Institute of Neurological Disease, University of California, San Francisco, San Francisco, Calif., United States

S1-02-03 Immune and injury response in neurodegeneration
Tony Wyss-Coray, Stanford University and VA Palo Alto Health Care, Palo Alto, Calif., United States

S1-02-04 Taupathy in Zebrafish Using Life Imaging
Dominik Paquet, Ludwig-Maximilians-Universität München, Munich, Germany

S1-02-05 Mitochondrial Dysfunction in Neurodegeneration
TBD

S1-02-06 Optometric Tools in Transgenesis and Neurodegeneration
TBD

S1-03 Prevention of Dementia

Chairs: Neill R Graff-Radford, Mayo Clinic, Jacksonville, Fla., United States
Monique Breteler, Erasmus University, Erasmus MC University Medical Center, Rotterdam, the Netherlands

S1-03-01 Exercise, Cognition and the Brain
Arthur Kramer, University of Illinois at Urbana-Champaign, Urbana-Champaign, Ill., United States

S1-03-02 Cognitive Training
Glenn Smith, Mayo Clinic, Rochester, Minn., United States

S1-03-03 Omega 3 Fatty Acids and the Brain
Stephan Cunnane, Research Center on Aging, Sherbrooke, QC, Canada

S1-03-04 Dietary Factors and Dementia
Pascale Barberger-Gateau, Victor Segalen University, Bordeaux, France

S1-03-05 Sleep and Dementia
Kristine Yaffe, University of San Francisco, San Francisco, Calif., United States

S1-03-06 Hypertension And Alzheimer's Disease: Further Steps Towards Prevention Strategy
Carole Dufouil, National Institute of Health and Medical Research, Paris, France

12:30-3 p.m.Poster presentations and lunch on your own

3-5 p.m.Oral sessions

6-9 p.m. Welcome reception